Mark Behrman
Analyst · Avondale Partners. Please proceed with your questions
Thanks, Dan. As Dan indicated, our fourth quarter results were disappointing compared to last year and what we expect going into the quarter. On page six of the presentation, we provide a consolidated summary statement of the operations for the fourth quarter of 2015 and the full year of 2015. Total net sales were down for the quarter driven by lower chemical sales, which contributed to the lower gross profit. I will go into some detail in the next few slides. Overall, SG&A increased $3.4 million for the quarter versus the fourth quarter of 2014. That increase was primarily driven by higher SG&A at our chemical business of approximately $1.1 million related to additional training expenses at El Dorado which we expect to end when the ammonia plant is in operation. Increased amortization cost related to the implementation of a new ERP system and increased compensation expense at El Dorado related to the overtime associated with the start up of the Nitric acid plant. In addition to that, we had higher corporate expenses arising primarily from one time severance cost of approximately $600,000 an increase in compensation and restricted stock award expense, the non allocation of certain executive salaries to the operating businesses that have been done in 2014 and increase in legal and professional fees related to various financing alternatives that were explored during the quarter, an increase direct to compensation. I want to point out that included in the fourth quarter of 2015 is $3.5 million write down of certain ammonia assets at our Pryor facility. Adjusted operating loss, adjusted net loss and adjusted EPS roll down for the quarter versus the fourth quarter of 2014 due to the decrease in sales and gross profit margins and the increase in SG&A that I just discussed. Page seven provides a summary of the chemical businesses operating results for the fourth quarter of 2015 compared to the fourth quarter of 2014. Sales and gross profit were both down for the quarter, primarily as a result of lower overall fertilizer selling prices and lower low density ammonium nitrate production and sales versus the fourth quarter of 2014 we were still under contract with Orica and they were required to pay for 60,000 tons per quarter of low density ammonium nitrate irrespective of the amount that they actually took. That combined with the increase in the SG&A discussed on the previous slide contributed to the adjusted operating loss for the quarter. Page eight provides a summary of the climate control businesses operating results for the fourth quarter of 2015 compared to the fourth quarter of 2014. Sales were slightly down for the quarter primarily from lower sales of residential feed pumps and gross profit decreased as a result of the lower sales. The gross profit as a percent of sales increased to approximately 50 basis points as a result of operational improvements being made throughout the business. SG&A was down for the quarter and that offset the loss in gross margins on a decreased sales resulting in operating income and EBITDA for the quarter that was slightly above last year. Lastly, our backlog at 12/31/15 was approximately $67 million which was up approximately $2 million from the prior year. Page nine outlines our expected capital spending for 2016. As Dan outlined earlier, we believe that the overall cost of the expansion project at El Dorado remains between $831 million and $855 million with the remaining CapEx on the El Dorado expansion as of the end of the year of between $126 million and $150 million including a contingency of $46 million at the top end of the range. However, as you heard earlier from Dan, our current thinking is that no more than half the contingency will be needed meaning that we believe we will come in at the lower end of the range. Additionally, we have planned CapEx in our Chemical business other than for the completion of the El Dorado expansion project of between $40 million and $48 million with another $8 million to $12 million in planned CapEx for both climate control and corporate. Keep in mind that some of the additional chemical CapEx may be deferred should we choose to do so without any impact on the reliability of the plants. Moving to page 10, we outlined our free cash flow. While we had a loss for the full year of 2015, we did have positive operating cash flow. Additionally we had significant capital expenditures during the year with a majority being spent on the expansion project at El Dorado. That resulted in negative free cash flow from operations for the year. We recently announced that we achieved mechanical completion on the new ammonia plant being constructed at El Dorado. We expect that plant to be operating and producing ammonia in the second quarter of 2016. We believe that will result in a significant reduction in capital expenditures, a significant improvement in operating results at our El Dorado facility and a generation of positive cash flow from operations. Turning now to page 11, we outlined our capital structure as of 12/31/15. In the fourth quarter of 2015, we closed on the $260 million in financing that we discussed during our third quarter earnings call. That financing included the issuance of $50 million of 12% senior secured notes and $210 million in preferred stocks and warrants. This is reflected in our capital structure. Total cash at the end of the year was approximately $127 million with total debt of approximately $530 million excluding the unamortized discount and issuance cost associated with our debt and $210 million announced to any preferred stock. Additionally at the end of the year our ABL facility was undrawn with a little over $64 million of availability. In February, we closed on a loan of $10 million against the Cogen facility that was built as part of the El Dorado expansion. We have the ability to borrow an additional $10 million against the Cogen facility and we are currently in discussions with additional lenders to secure debt. We will also receive an additional $5 million representing the balance of our loan on the ammonia storage tank when it is complete which we believe will be in the second quarter of this year. Lastly, our loan on our Marcellus shale assets was due on February 1st. Our lender agreed to push out the maturity date to April 1st in order for us to mutually determine the possibility of a refinance. We are now near the start up of the El Dorado ammonia plant which will signal the completion of the El Dorado expansion projects. Once the plant is in operation for a period of time, we intend to seek to refinance our capital structure in order to improve our liquidity and to reduce our overall cost to capital. Please turn to page 12, at this time I’d like to discuss our liquidity position and our cash needs for the full year of 2016 as of the end of the year. Our cash needs assuming the top end of the range are as follows. Remaining CapEx needed to complete the El Dorado expansion project of $150 million, other planned CapEx for 2016 for chemical, climate control and corporate of $60 million. Total interest and principal payments on our outstanding debt of $45 million and the repayment of the Zena loan assuming that we will not be able to refinance the $40 million so therefore we have a total cash need for 2016 assuming the high end of the planned CapEx range of $269 million. I have not included the dividend payments in our preferred stock as our expectation is that we will be accruing those payments for 2016. To fund our 2016 cash needs, we have cash balance at the end of the year of $127 million. Financing on our Cogen facility of $20 million remaining funding on our ammonia storage tank when completed of another $5 million, so that will be a total of $152 million of sources of funds and leaving a gap of $117 million in funding, assuming that we spend the full $150 million to complete the El Dorado expansion project. As Dan mentioned earlier, our current thinking is that we do not anticipate spending more than half of the $46 million in contingency included in that number. So the $117 million in funding needed should really be $94 million. Additionally, I have included the high end of the range for other planned CapEx which we believe is conservative. We expect that GAAP of $94 million to be funded by cash flows from a full year of 2016 operations and if needed a draw on our ABL facility which has over $64 million in availability. Additionally, as I mentioned earlier, some of the additional chemical CapEx for 2016 of $48 million may be deferred to 2017 without any impact on the reliability of the plants should we need to do so. At this time we believe that we have sufficient liquidity to meet our capital needs for 2016 and to continue to effectively operate our businesses. Now I’ll turn it back to Dan to discuss the status of our chemical operations and the status of the El Dorado expansion project.